⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GILD News
Gilead Sciences Inc
Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care
prnewswire.com
DAWN
TCRX
ENGN
ONCY
GILD
Semafor Unveils 450 Top Global CEOs and Government Leaders for Semafor World Economy 2026
prnewswire.com
HON
LLY
LAZ
QCOM
GS
BAH
BKR
PNC
ALL
MET
EXPE
JLL
MSFT
GOOG
NVDA
META
CRWD
VZ
BEN
CAVA
IBM
AMZN
INTC
AMD
CSCO
PANW
ETSY
UBER
LYFT
GE
USFD
SBUX
MCD
YUM
CVS
MRNA
PFE
JNJ
ABBV
BMY
GILD
REGN
AMGN
BIIB
VRTX
AZN
NVO
LULU
URBN
RL
MAT
UAA
INFY
ARM
ISRG
TDOC
TAP
FSLR
NEE
BE
PLUG
FCEL
RUN
SEDG
ENPH
ALNY
CRSP
EDIT
NTLA
ACLS
EXAS
ASO
ATHM
COIN
PYPL
MPWR
ON
AMAT
LRCX
KLAC
ASML
ADI
NXPI
TXN
WIT
HPE
OKTA
FTNT
DDOG
SNOW
PLTR
SPCE
RBLX
IAB Connected Commerce Summit to Highlight the Path for Scalable, Sustainable Commerce Media
prnewswire.com
CRTO
DV
UBER
UL
GILD
KOD
Chainguard Launches Commercial Builds with Industry Leaders, Setting a New Standard for Verifiable, Zero-Vulnerability Software
prnewswire.com
ESTC
GLBZ
GRAF
TIGR
SNOW
FTNT
HPE
OPEN
CHKP
CAN
PANW
CRWD
ZS
DDOG
MDB
SMCI
AMD
NVDA
INTC
AMZN
GOOG
MSFT
IBM
ORCL
CRM
ADBE
PYPL
NFLX
CMCSA
DIS
VZ
T
KO
PEP
JNJ
PG
XOM
CVX
UNH
JPM
BAC
WFC
C
GS
MS
AMGN
GILD
BMY
PFE
MRK
ABBV
LLY
MDT
ISRG
COST
WMT
HD
MCD
SBUX
NKE
BA
CAT
GE
HON
RTX
LMT
GD
MMC
AXP
V
MA
MSCI
ADP
AMAT
ASML
QCOM
AVGO
TXN
ADSK
CDNS
SNPS
MRVL
GOOGL
Pseudomonal Infections Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 10+ Leading Players Wheeling the Therapeutics Landscape
globenewswire.com
ARMP
GILD
Arcellx Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcellx, Inc. - ACLX
businesswire.com
ACLX
GILD
Pharma Leaders Discuss Managing Revenue Management System Updates at Model N Rainmaker Panel Hosted by RevSavvy
prnewswire.com
GILD
ASND
ABBV
Saudi Arabia Cell and Gene Therapy Manufacturing Market Trends and Future Forecast, 2035
globenewswire.com
MRNA
PFE
BMY
GILD
Orthobiologics Market to Surpass USD 9 Billion by 2031 Amid Rising Osteoarthritis Cases and Advancements in Regenerative Therapies, Says Mordor Intelligence
globenewswire.com
PFE
AZN
GILD
CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight
prnewswire.com
GILD
INCY
BIIB
NVS
AMGN
JNJ
ABBV
BMY
AZN
MRK
PFE
TGTX
XNCR
CABA
IMUX
ZNTL
GLPG
CLNN
AUTL